Your browser doesn't support javascript.
loading
BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?
Morgan, Robert D; Burghel, George J; Flaum, Nicola; Bulman, Michael; Smith, Philip; Clamp, Andrew R; Hasan, Jurjees; Mitchell, Claire L; Salih, Zena; Woodward, Emma R; Lalloo, Fiona; Crosbie, Emma J; Edmondson, Richard J; Wallace, Andrew J; Jayson, Gordon C; Evans, D Gareth R.
Affiliation
  • Morgan RD; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK. robert.morgan7@nhs.net.
  • Burghel GJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. robert.morgan7@nhs.net.
  • Flaum N; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Bulman M; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Smith P; Division of Evolution & Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Clamp AR; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Hasan J; Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, Manchester, UK.
  • Mitchell CL; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Salih Z; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Woodward ER; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Lalloo F; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Crosbie EJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
  • Edmondson RJ; Division of Evolution & Genomic Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
  • Wallace AJ; Department of Clinical Genetics, Manchester University NHS Foundation Trust, Manchester, UK.
  • Jayson GC; Department of Clinical Genetics, Manchester University NHS Foundation Trust, Manchester, UK.
  • Evans DGR; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Br J Cancer ; 127(1): 163-167, 2022 07.
Article in En | MEDLINE | ID: mdl-35260807
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Germ-Line Mutation Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Germ-Line Mutation Type of study: Prognostic_studies Limits: Aged / Female / Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article Affiliation country: United kingdom